BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17163262)

  • 1. Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study.
    Shrivastava R; Pechadre JC; John GW
    Clin Drug Investig; 2006; 26(5):287-96. PubMed ID: 17163262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
    Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
    Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple pharmacological and toxicological investigations on Tanacetum parthenium and Salix alba extracts: Focus on potential application as anti-migraine agents.
    di Giacomo V; Ferrante C; Ronci M; Cataldi A; Di Valerio V; Rapino M; Recinella L; Chiavaroli A; Leone S; Vladimir-Knežević S; Kindl M; Brunetti L; Menghini L; Orlando G
    Food Chem Toxicol; 2019 Nov; 133():110783. PubMed ID: 31491430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study.
    Guilbot A; Bangratz M; Ait Abdellah S; Lucas C
    BMC Complement Altern Med; 2017 Aug; 17(1):433. PubMed ID: 28854909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study.
    Diener HC; Pfaffenrath V; Schnitker J; Friede M; Henneicke-von Zepelin HH
    Cephalalgia; 2005 Nov; 25(11):1031-41. PubMed ID: 16232154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache.
    Moscano F; Guiducci M; Maltoni L; Striano P; Ledda MG; Zoroddu F; Raucci U; Villa MP; Parisi P
    Ital J Pediatr; 2019 Mar; 45(1):36. PubMed ID: 30871574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the antimigraine action of Feverfew (Tanacetum parthenium (L.) Sch. Bip.)].
    Studzińska-Sroka E; Znajdek-Awizeń P; Gawron-Gzella A
    Wiad Lek; 2013; 66(2 Pt 2):195-9. PubMed ID: 25775817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine.
    Cady RK; Goldstein J; Nett R; Mitchell R; Beach ME; Browning R
    Headache; 2011; 51(7):1078-86. PubMed ID: 21631494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feverfew for preventing migraine.
    Pittler MH; Ernst E
    Cochrane Database Syst Rev; 2004; (1):CD002286. PubMed ID: 14973986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial.
    Maizels M; Blumenfeld A; Burchette R
    Headache; 2004 Oct; 44(9):885-90. PubMed ID: 15447697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention.
    Murphy JJ; Heptinstall S; Mitchell JR
    Lancet; 1988 Jul; 2(8604):189-92. PubMed ID: 2899663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of feverfew as prophylactic treatment of migraine.
    Johnson ES; Kadam NP; Hylands DM; Hylands PJ
    Br Med J (Clin Res Ed); 1985 Aug; 291(6495):569-73. PubMed ID: 3929876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review.
    Ernst E; Pittler MH
    Public Health Nutr; 2000 Dec; 3(4A):509-14. PubMed ID: 11276299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feverfew as a preventive treatment for migraine: a systematic review.
    Vogler BK; Pittler MH; Ernst E
    Cephalalgia; 1998 Dec; 18(10):704-8. PubMed ID: 9950629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feverfew for preventing migraine.
    Pittler MH; Vogler BK; Ernst E
    Cochrane Database Syst Rev; 2000; (3):CD002286. PubMed ID: 10908545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study.
    Ferro EC; Biagini AP; da Silva ÍE; Silva ML; Silva JR
    Acupunct Med; 2012 Dec; 30(4):252-7. PubMed ID: 22961605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Feverfew as a prophylactic treatment of migraine].
    Prusiński A; Durko A; Niczyporuk-Turek A
    Neurol Neurochir Pol; 1999; 33 Suppl 5():89-95. PubMed ID: 10719691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feverfew for migraine prophylaxis: a systematic review.
    Saranitzky E; White CM; Baker EL; Baker WL; Coleman CI
    J Diet Suppl; 2009; 6(2):91-103. PubMed ID: 22435410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioassay-guided isolation of apigenin with GABA-benzodiazepine activity from Tanacetum parthenium.
    Jäger AK; Krydsfeldt K; Rasmussen HB
    Phytother Res; 2009 Nov; 23(11):1642-4. PubMed ID: 19441011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.